Vertex Pharma (VRTX) volatility elevated as shares sell off on AASLD meeting update.

November 8, 2011 2:38 PM EST
Vertex Pharma (Nasdaq: VRTX) November call option implied volatility is at 68, December is at 62, January is at 59; above its 26-week average of 48 according to Track Data, suggesting larger price movement following an AASLD meeting update.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Options

Related Entities

Options